IPI Legacy Liquidation Co
DelistedCIK 1445499fmd_1GA8B3M6C6Z1RK1SNKZHNVRMRGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 02, 2019 to Sep 30, 2023, 15 periods
| Line item | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Total revenues | – | 1 | 13 |
| Cost of revenue | – | 1 | 6 |
| Net interest income | – | (4) | (14) |
| Gross profit | – | 0 | 6 |
| Research and development | 28 | 21 | 11 |
| Total operating expenses | 45 | 71 | 89 |
| Operating income | (45) | (71) | (83) |
| Other non-operating income (expense) | (0) | (1) | (9) |
| Income before taxes | (46) | (77) | (106) |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | (46) | (77) | (106) |
| Net income | (46) | (77) | (106) |
| Net income to common shareholders | (46) | (77) | (106) |